Therapy of Venezuelan Patients with Severe Mucocutaneous or Early Lesions of Diffuse Cutaneous Leishmaniasis with a Vaccine Containing Pasteurized Leishmania Promastigotes and Bacillus Calmette-Guerin - Preliminary Report Jacinto Convit, Marian Ulrich, María Argelia Polegre, Angela Avila, Noris Rodríguez, Marilina Mazzedo, Belkis Blanco PAGE: 57-62

Atypical Mucocutaneous Leishmaniasis Caused by Leishmania braziliensis in an Acquired Immunodeficiency Syndrome Patient: T-cell Responses and Remission of Lesions Associated with Antigen Immunotherapy Alda M Da-Cruz, Danilo V Filgueiras, Ziadir Coutinho, Wilson Mayrink, Gabriel Grimaldi Jr, Paula M De Luca, Sergio CF Mendonça, Sergio G Coutinho PAGE: 537-542

Immunotherapy for Visceral Leishmaniasis: Ability of Factors Produced during Anti-leishmania Responses of Skin Test Positive Adults to Inhibit Peripheral Blood Mononuclear Cell Activities Associated with Visceral Leishmaniasis Bettie J Holaday PAGE: 55-66

Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved* Joseli Lannes-Vieira, Glaucia Vilar-Pereira, Leda Castaño Barrios, Andrea Alice Silva DOI: 10.1590/0074-02760220287